21h
Alumis Shares Phase 3 Psoriasis Details, Targets 2H NDA Filing at Oppenheimer Healthcare Conference
Executives from Alumis (NASDAQ:ALMS) outlined upcoming regulatory milestones and provided additional context around recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results